Global Drug-Device Combination Products Competitive Landscape Professional Research Report 2025
Research Summary
Drug-device combination products are specialized medical products that combine a pharmaceutical drug with a medical device in a single package or system. These products are designed to work together to provide a specific therapeutic effect or treatment approach. Examples include inhalers that deliver medication directly to the lungs, insulin pens that facilitate the administration of insulin, and transdermal patches that deliver drugs through the skin. These combination products often offer enhanced convenience, improved drug delivery accuracy, and better patient compliance compared to using drugs or devices separately. Their development and regulation involve considerations from both the pharmaceutical and medical device industries, ensuring safety, efficacy, and proper functionality of the combined components.
According to DIResearch's in-depth investigation and research, the global Drug-Device Combination Products market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Medtronic, Boehringer Ingelheim, Mylan, 3M, Smith & Nephew, Hisamitsu, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drug-Device Combination Products. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug-Device Combination Products market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug-Device Combination Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug-Device Combination Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drug-Device Combination Products Include:
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Medtronic
Boehringer Ingelheim
Mylan
3M
Smith & Nephew
Hisamitsu
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Drug-Device Combination Products Product Segment Include:
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Drug-Device Combination Products Product Application Include:
Hospital and Clinic
Retail Pharmacies
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drug-Device Combination Products Industry PESTEL Analysis
Chapter 3: Global Drug-Device Combination Products Industry Porter’s Five Forces Analysis
Chapter 4: Global Drug-Device Combination Products Major Regional Market Size and Forecast Analysis
Chapter 5: Global Drug-Device Combination Products Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drug-Device Combination Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drug-Device Combination Products Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Drug-Device Combination Products Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drug-Device Combination Products Product by Type
- 1.2.1 Drug-Coated Device
- 1.2.2 Prefilled Drug Delivery Systems
- 1.2.3 Nebulizer and Inhaler
- 1.2.4 Transdermal Delivery System
- 1.2.5 Others
- 1.3 Drug-Device Combination Products Product by Application
- 1.3.1 Hospital and Clinic
- 1.3.2 Retail Pharmacies
- 1.3.3 Other
- 1.4 Global Drug-Device Combination Products Market Size Analysis (2020-2032)
- 1.5 Drug-Device Combination Products Market Development Status and Trends
- 1.5.1 Drug-Device Combination Products Industry Development Status Analysis
- 1.5.2 Drug-Device Combination Products Industry Development Trends Analysis
- 2 Drug-Device Combination Products Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drug-Device Combination Products Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drug-Device Combination Products Market Analysis by Regions
- 4.1 Drug-Device Combination Products Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Drug-Device Combination Products Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Drug-Device Combination Products Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Drug-Device Combination Products Revenue Forecast by Region (2026-2032)
- 5 Global Drug-Device Combination Products Market Size by Type and Application
- 5.1 Global Drug-Device Combination Products Market Size by Type (2020-2032)
- 5.2 Global Drug-Device Combination Products Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Drug-Device Combination Products Market Size by Type
- 6.4 North America Drug-Device Combination Products Market Size by Application
- 6.5 North America Drug-Device Combination Products Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Drug-Device Combination Products Market Size by Type
- 7.4 Europe Drug-Device Combination Products Market Size by Application
- 7.5 Europe Drug-Device Combination Products Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Drug-Device Combination Products Market Size by Type
- 8.4 China Drug-Device Combination Products Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Drug-Device Combination Products Market Size by Type
- 9.4 APAC (excl. China) Drug-Device Combination Products Market Size by Application
- 9.5 APAC (excl. China) Drug-Device Combination Products Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Drug-Device Combination Products Market Size by Type
- 10.4 Latin America Drug-Device Combination Products Market Size by Application
- 10.5 Latin America Drug-Device Combination Products Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Drug-Device Combination Products Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Drug-Device Combination Products Market Size by Type
- 11.4 Middle East & Africa Drug-Device Combination Products Market Size by Application
- 11.5 Middle East & Africa Drug-Device Combination Products Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Drug-Device Combination Products Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Drug-Device Combination Products Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Drug-Device Combination Products Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 GSK
- 13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 GSK Drug-Device Combination Products Product Portfolio
- 13.1.3 GSK Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Novo Nordisk
- 13.2.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Novo Nordisk Drug-Device Combination Products Product Portfolio
- 13.2.3 Novo Nordisk Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Eli Lilly
- 13.3.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Eli Lilly Drug-Device Combination Products Product Portfolio
- 13.3.3 Eli Lilly Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 AstraZeneca
- 13.4.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 AstraZeneca Drug-Device Combination Products Product Portfolio
- 13.4.3 AstraZeneca Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Sanofi
- 13.5.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Sanofi Drug-Device Combination Products Product Portfolio
- 13.5.3 Sanofi Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Boston Scientific
- 13.6.1 Boston Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Boston Scientific Drug-Device Combination Products Product Portfolio
- 13.6.3 Boston Scientific Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Abbott
- 13.7.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Abbott Drug-Device Combination Products Product Portfolio
- 13.7.3 Abbott Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Medtronic
- 13.8.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Medtronic Drug-Device Combination Products Product Portfolio
- 13.8.3 Medtronic Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Boehringer Ingelheim
- 13.9.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Boehringer Ingelheim Drug-Device Combination Products Product Portfolio
- 13.9.3 Boehringer Ingelheim Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Mylan
- 13.10.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Mylan Drug-Device Combination Products Product Portfolio
- 13.10.3 Mylan Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 3M
- 13.11.1 3M Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 3M Drug-Device Combination Products Product Portfolio
- 13.11.3 3M Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Smith & Nephew
- 13.12.1 Smith & Nephew Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Smith & Nephew Drug-Device Combination Products Product Portfolio
- 13.12.3 Smith & Nephew Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Hisamitsu
- 13.13.1 Hisamitsu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Hisamitsu Drug-Device Combination Products Product Portfolio
- 13.13.3 Hisamitsu Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Molnlycke
- 13.14.1 Molnlycke Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Molnlycke Drug-Device Combination Products Product Portfolio
- 13.14.3 Molnlycke Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Teleflex
- 13.15.1 Teleflex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Teleflex Drug-Device Combination Products Product Portfolio
- 13.15.3 Teleflex Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 BD
- 13.16.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 BD Drug-Device Combination Products Product Portfolio
- 13.16.3 BD Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Lepu Medical
- 13.17.1 Lepu Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Lepu Medical Drug-Device Combination Products Product Portfolio
- 13.17.3 Lepu Medical Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 MicroPort
- 13.18.1 MicroPort Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 MicroPort Drug-Device Combination Products Product Portfolio
- 13.18.3 MicroPort Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.19 Terumo
- 13.19.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Terumo Drug-Device Combination Products Product Portfolio
- 13.19.3 Terumo Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.20 B. Braun
- 13.20.1 B. Braun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 B. Braun Drug-Device Combination Products Product Portfolio
- 13.20.3 B. Braun Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.21 Antares Pharma
- 13.21.1 Antares Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.21.2 Antares Pharma Drug-Device Combination Products Product Portfolio
- 13.21.3 Antares Pharma Drug-Device Combination Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Drug-Device Combination Products Industry Chain Analysis
- 14.2 Drug-Device Combination Products Industry Raw Material and Suppliers Analysis
- 14.2.1 Drug-Device Combination Products Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Drug-Device Combination Products Typical Downstream Customers
- 14.4 Drug-Device Combination Products Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook